Diabetic Kidney Disease: A Call to Action: Preface

por Tuttle, Katherine R.
Publicado 2015

Back to the Future: Glomerular Hyperfiltration and the Diabetic Kidney

por Tuttle, Katherine R.
Publicado 2017

Impact of the COVID-19 pandemic on clinical research

por Tuttle, Katherine R.
Publicado 2020

Digging deep into cells to find mechanisms of kidney protection by SGLT2 inhibitors

por Tuttle, Katherine R.
Publicado 2023

Authors’ Response to Peer Reviews of “Use of Smartphone Apps for Improving Physical Function Capacity in Cardiac Patient Rehabilitation: Systematic Review”

por Tuttle, Katherine, Kelemen, Arpad, Liang, Yulan
Publicado 2021

Use of Smartphone Apps for Improving Physical Function Capacity in Cardiac Patient Rehabilitation: Systematic Review

por Tuttle, Katherine, Kelemen, Arpad, Liang, Yulan
Publicado 2021

Cardio-Renal-Metabolic Care Models: Toward Achieving Effective Interdisciplinary Care

por Rangaswami, Janani, Tuttle, Katherine, Vaduganathan, Muthiah
Publicado 2020

Glycemic Variability and KIM-1–Induced Inflammation in the Diabetic Kidney

por Tuttle, Katherine R., Alicic, Radica Z.
Publicado 2021

Evidence‐based treatment of hyperglycaemia with incretin therapies in patients with type 2 diabetes and advanced chronic kidney disease

por Tuttle, Katherine R., McGill, Janet B.
Publicado 2020

Novel systemic treatments in atopic dermatitis: Are there sex differences?

por Tuttle, Katherine L., Forman, Jessica, Beck, Lisa A.
Publicado 2021

Mechanisms and clinical applications of incretin therapies for diabetes and chronic kidney disease

por Alicic, Radica Z., Neumiller, Joshua J., Tuttle, Katherine R.
Publicado 2023

Post-acute COVID-19 syndrome and kidney diseases: what do we know?

por Copur, Sidar, Berkkan, Metehan, Basile, Carlo, Tuttle, Katherine, Kanbay, Mehmet
Publicado 2022

Glucagon-like peptide-1 receptor agonists in diabetic kidney disease: A review of their kidney and heart protection

por Michos, Erin D., Bakris, George L., Rodbard, Helena W., Tuttle, Katherine R.
Publicado 2023

Use of Glucose-Lowering Agents in Diabetes and CKD

por Alicic, Radica Z., Neumiller, Joshua J., Galindo, Rodolfo J., Tuttle, Katherine R.
Publicado 2022

Clinical Evidence and Proposed Mechanisms for Cardiovascular and Kidney Benefits from Sodium–Glucose Co-transporter-2 Inhibitors

por Neumiller, Joshua J, Lienhard, Fredrick J, Alicic, Radica Z, Tuttle, Katherine R
Publicado 2022

Enthesitis as a component of dactylitis in psoriatic juvenile idiopathic arthritis: histology of an established clinical entity

por Tuttle, Katherine SL, Vargas, Sara O, Callahan, Michael J, Bae, Donald S, Nigrovic, Peter A
Publicado 2015

Erratum. Sodium–Glucose Cotransporter 2 Inhibition and Diabetic Kidney Disease. Diabetes 2019;68:248–257

por Alicic, Radica Z., Neumiller, Joshua J., Johnson, Emily J., Dieter, Brad, Tuttle, Katherine R.
Publicado 2019

Disseminated Adenovirus Nephritis After Kidney Transplantation

por Hatlen, Timothy, Mroch, Henry, Tuttle, Katherine, Ojogho, Okechukwu, Rooney, Michele, Desmond, Sara, Bani-Hani, Samer
Publicado 2017

Urinary excretion of RAS, BMP, and WNT pathway components in diabetic kidney disease

por Afkarian, Maryam, Hirsch, Irl B., Tuttle, Katherine R., Greenbaum, Carla, Himmelfarb, Jonathan, de Boer, Ian H.
Publicado 2014

Effects of once‐weekly dulaglutide on kidney function in patients with type 2 diabetes in phase II and III clinical trials

por Tuttle, Katherine R., McKinney, T. Dwight, Davidson, Jaime A., Anglin, Greg, Harper, Kristine D., Botros, Fady T.
Publicado 2016